Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Structural modification at the 2′-O-position of riboses in oligonucleotide therapeutics is of critical importance for their use as drugs. To date, the methoxyethyl (MOE) substituent is the most important and features in dozens of antisense oligonucleotides that have been tested in clinical trials. Yet, the search for new improved modifications continues in a quest for increased oligonucleotide potency, improved transport in vivo and favorable metabolism. Recently, we described how the conjugation of spermine groups to pyrimidines in oligonucleotides vastly increases their affinity for complementary RNAs through accelerated binding kinetics. Here we describe how spermines can be linked to the exocyclic amino groups of cytidines in MOE-oligonucleotides employing a straightforward ‘convertible nucleoside approach’ during solid phase synthesis. Singly- or doubly-modified oligonucleotides show greatly enhanced affinity for complementary RNA, with potential for a new generation of MOE-based oligonucleotide drugs.

Original publication

DOI

10.1002/hlca.201900222

Type

Journal article

Journal

Helvetica Chimica Acta

Publication Date

01/12/2019

Volume

102